Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.

Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants

Open access

Abstract

The high-specific-activity factor IX (FIX) variant Padua (R338L) is the most promising transgene for hemophilia B (HB) gene therapy. Although R338 is strongly conserved in mammalian evolution, amino acid substitutions at this position are underrepresented in HB databases. We therefore undertook a complete 20 amino acid scan and determined the specific activity of human (h) and canine (c) FIX variants with every amino acid substituted at position 338. Notably, we observe that hFIX-R338L is the most active variant and cFIX-R338L is sevenfold higher than wild-type (WT) cFIX. This is consistent with the previous identification of hFIX-R338L as a cause of a rare X-linked thrombophilia risk factor. Moreover, WT hFIX and cFIX are some of the least active variants. We confirmed the increased specific activity relative to FIX-WT in vivo of a new variant, cFIX-R338I, after gene therapy in an HB dog. Last, we screened 232 pediatric subjects with thromboembolic disease without identifying F9 R338 variants. Together these observations suggest a surprising evolutionary pressure to limit FIX activity with WT FIX rather than maximize FIX activity.

Overview

Integrity signals

Registry

Crossref · 10.1182/bloodadvances.2019000405

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Cited by

See all 31

Metadata

Authors
Samelson-Jones, B. J., Finn, J. D., Raffini, L. J., Merricks, E. P., Camire, R. M., Nichols, T. C., & Arruda, V. R.
Affiliations
  • Divsion of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA;
  • Children's Hospital of Philadelphia (US)
  • University of North Carolina at Chapel Hill (US)
Venue
Blood Advances
Published
2021-03-03
Volume
5
Issue
5
Pages
1324-1332
ISSN
  • 2473-9529 (ISSN-L)
  • 2473-9537
OpenAlex
W3134932784
Cited by
31
References
40
Citations by year
2026: 5 · 2025: 8 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 4
FWCI
2.93
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Blood Advances (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Blood Foundation
  • National Heart, Lung, and Blood Institute (K08HL140078, P01HL064190, P01HL139420)
Topics
  • Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Keywords
coagulation factor IX, hemophilia B, gene therapy, canine model, specific activity, evolutionary conservation, thromboembolism, pediatric patients
MeSH terms
Animals, Blood Coagulation, Blood Coagulation Tests, Child, Hemophilia B, Dogs, Factor IX, Humans, Genetic Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants. https://app.cochat.ai/papers/10.1182/bloodadvances.2019000405
The paper
Samelson-Jones, B. J., Finn, J. D., Raffini, L. J., Merricks, E. P., Camire, R. M., Nichols, T. C., & Arruda, V. R. (2021). Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants. Blood Advances. https://doi.org/10.1182/bloodadvances.2019000405

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.